CSIMarket
 


Covetrus Inc.  (CVET)
Other Ticker:  
 

Cumulative Covetrus's Working Capital Ratio for Trailing Twelve Months Period

CVET's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CVET Working Capital Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Current Liabilities Growth 3.39 % 11.73 % -4.51 % -0.83 % -11.38 %
Y / Y Current Assets Growth -2.89 % -0.35 % -9.93 % -8.96 % -2.81 %
Working Capital Ratio for Trailing Twelve Months Period 1.89 1.92 1.98 2.01 2.05
Total Ranking # 2795 # 2938 # 2829 # 2298 # 2203
Seq. Current Liabilities Growth -3.81 % 9.17 % -2.24 % 0.71 % 3.96 %
Seq. Current Assets Growth -2.75 % 4.89 % 0 % -4.79 % -0.21 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2022
On the trailing twelve months basis Due to decrease in Current Liabilities in the II. Quarter to $733 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 1.89 below Covetrus Inc. average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Pharmacy Services & Retail Drugstore industry 4 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Covetrus. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about CVET
Working Capital Ratio CVET in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 5
Sector # 64
S&P 500 # 2765


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.05 1.9 1.7
(Jun 30 2021)   (Dec 31 2019)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Pharmacy Services & Retail Drugstore Industry Working Capital Ratio for Trailing Twelve Months Period
Medavail Holdings Inc   4.63 
Trxade Health Inc   3.39 
Petiq Inc   2.76 
Herbalife Ltd   2.13 
Aixin Life International Inc   2.12 
Covetrus Inc.  1.91 
Nu Skin Enterprises Inc   1.76 
Rite Aid Corp  1.29 
Cosmos Health Inc   1.25 
111 Inc   1.25 
Sharing Services Global Corporation  1.23 
Cardinal Health Inc   1.10 
Bimi International Medical Inc   1.04 
Mckesson Corporation  0.98 
Cvs Health Corporation  0.92 
Can B Corp   0.82 
Walgreens Boots Alliance Inc   0.79 
Trees Corporation  0.66 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com